OKYO Pharma Limited (OKYO) NASDAQ
1.70
-0.015(-0.88%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.70
-0.015(-0.88%)
Currency In USD
| Market Cap | 50.15M |
| Enterprise Value | 48.59M |
| P/E Ratio | -13.75 |
| PEG Ratio | -0.18 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -18.57 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -6.36 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.99 |
| Return On Equity | 1.03 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2,563 |
| EBITDA | -7.08M |
| Net Income | -4.71M |
| Diluted EPS | -0.12 |
| Total Cash | 4.22M |
| Total Cash/Share | 0.11 |
| Total Debt | 185,795 |
| Total Debt/Equity | -0.05 |
| Current Ratio | 0.58 |
| Book Value Per Share | -0.09 |
| 52-Week Change | -3.14 |
| 52-Week High | 3.35 |
| 52-Week Low | 1.44 |
| Moving Average 50 Days | 1.61 |
| Moving Average 200 Days | 2 |
| Average Volume | 77,795 |
| Shares Outstanding | 38.37M |
| % Held by Institutions | 0.13 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |